Poster Abstract Session:
168. Stewardship: Improving Outcomes
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, Investigative ID, Pediatric ID


Presentations:
An Offer You Can’t Refuse: Clinical Impact of Accepting or Rejecting a Recommendation from an Antibiotic Stewardship Program
Alex Carignan, MD, MSc, FRCPC; Adam Mercier, MD; Julie Perron, B.Pharm., M.Sc.; Vincent Nault, M.Sc.; Isabelle Alarie, MD; Cybele Bergeron, MD; Mathieu Beaudoin, Ph.D.; Louis Valiquette, MD, MSc, FRCPC
Posters
  • 1541_IDWPOSTER.pdf (814.4 kB)
  • A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
    Anthony M. Boyd, PharmD, BCPS; Jerod Nagel, PharmD, BCPS; Gregory Eschenauer, PharmD, BCPS; Vincent D. Marshall, BS, MS; Tejal Gandhi, MD; Carol Chenoweth, MD, MS, FSHEA, FIDSA; Lindsay Petty, MD; Daniel McClung, MD; Twisha S. Patel, PharmD, BCPS
    Impact of System-wide Adoption of CDC Core Elements on Antimicrobial Use and Clostridium difficile Infection in a Large Health System
    Roy Guharoy, PharmD, MBA; Florian Daragjati, PharmD, BCPS; Clariecia Groves, M.S.; Danielle Sebastian, PharmD; Jeffrey Seggerman, MBA; Angelo Bufalino, Ph.D.; Ann Hendrich, RN, PhD; Mohamad Fakih, MD, MPH
    Posters
  • IDSA-poster-CDCcore-2017.pdf (425.1 kB)
  • Reduction of Clostridium difficile Infection in a Community Teaching Hospital Associated with Antimicrobial Stewardship Team Interventions on Fluoroquinolone Utilization
    Paula Politis, PharmD, BCPS; Virginia Abell, BA, RN, CIC; Lisa Hoisington, PharmD, BCPS; Michael J. Tan, MD, FACP, FIDSA; Thomas M. File Jr., MD
    Posters
  • ID_Week_2017_Final.pdf (536.6 kB)
  • Impact of a Stewardship Initiative to Decrease Treatment of Asymptomatic Bacteriuria and Pyuria in the Emergency Department
    Jessica Smith, PharmD; John Williamson, PharmD; James Johnson, PharmD; Jennifer Hannum, MD; Christopher Ohl, MD, FIDSA; Vera Luther, MD; James Beardsley, PharmD
    Posters
  • IDWeek Poster_JSmith v2.pdf (472.9 kB)
  • Clinical Outcome Evaluation of an Antimicrobial Stewardship Program in an Accountable Care Organization
    Meredith Baumgartner, MPH; Julie Giddens, PharmD BCPS; Carl Asche, PhD; Jinma Ren, PhD; Saqib Walayat, MD; Muhammad Asghar, MD; John Cotter, MD
    The effect of the preauthorization system on oral antimicrobials at a maternal and children’s hospital in Japan
    Noriko Kinoshita, MD; Makoto Komura, PharmD; Yusuke Okubo, MD, MPH; Kensuke Shoji, MD; Isao Miyairi, MD
    Eight Years of Antimicrobial Stewardship Program (ASP) at a Large Academic Medical Center: Antibiotic Utilization, Hospital-onset Clostridium difficile infection (HO-CDI) and Resistance Trends.
    Yanina Dubrovskaya, PharmD, BCPS (AQ-ID), AAHIVP; Anna Stachel, MPH, CIC; Kenneth Inglima, MS; Justin Siegfried, PharmD, BCPS; Shin-Pung (Polly) Jen, PharmD, BCPS (AQ-ID), AAHIVP; Vinh Pham, MD, PhD; Maria Aguero-Rosenfeld, MD; Michael Phillips, MD
    Posters
  • IDSAPoster_final.pdf (221.0 kB)
  • Clinical Impact of an Antibiotic Stewarship Program at Two Non-Teaching Community Hospitals
    Jennifer Bui, Pharm. D.; Colleen M. Clay, RN, BSN, CIC; Mehboob Rehan, MD; Kristi Sharland, BS, MT(ASCP); Faheem Younus, MD, FIDSA
    Clinical Impact of Antimicrobial Stewardship Programs in Colombian Acute Care Hospitals
    Cristhian Hernández-Gómez, MSc; Christian Pallares, MD, MSc; Sergio Reyes, MD; Max Feinstein, BA; Sergio Gutiérrez, Bac; Soraya Salcedo, MD, MSc; Ernesto Martínez, MD; David Aragon, MD; Sara Cobo, MD; Maria Virginia Villegas, MD, MSc, FIDSA
    Outcomes of Bedside Nurse-Driven Interdisciplinary Antibiotic Stewardship and Infection Prevention Rounds
    David Ha, PharmD; Mary Bette Forte, MSN-Ed, RN; Kim Nguyen, BS; Vickie Ancheta, RN; Nora Catipon, RN, MSN, GNP-BC; Sarah Chan, PharmD; Donna Lira, RN, CIC; Jessica Legge, RN; Rita Olans, DNP, CPNP, APRN; Daniel Gluckstein, MD; Mamta Desai, CLS, MBA, CIC; John Mourani, MD; Richard Olans, MD; Gurbinder Sadana, MD
    Vancomycin Safety Monitoring Using an Electronic Health Record Database
    Michael P Veve, PharmD; Rachel M Kenney, PharmD; Jack Jordan, MS; Tom Smoot, PharmD; Marilen Martinez, PharmD; Ronald Kendall, PharmD; Ayesha Hyder, PharmD; Susan L Davis, PharmD
    Posters
  • VeveMP_VancoAKI_IDWeek2017.pdf (319.8 kB)
  • Efficacy and Safety of a Vancomycin (VAN) Dosing Protocol Developed for Morbidly Obese (MO) Patients
    Paige A Taylor, PharmD; Lea Mollon, PharmD; Jennifer Pisano, MD; Natasha N Pettit, PharmD; Zhe Han, PharmD
    Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
    Nadya Jammal, PharmD; Dayna Mcmanus, PharmD; Samad Tirmizi, PharmD; Jeffrey Topal, MD
    Posters
  • Zosyn_Poster.pdf (562.0 kB)
  • Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
    Nandita S. Mani, MD; Paul S. Pottinger, MD, FIDSA; Moni Blazej Neradilek, MS; Andrew Bryan, MD, PhD; Catherine Liu, MD, FIDSA; Rupali Jain, Pharm.D., FIDSA
    Impact of an Antimicrobial Stewardship Bloodstream Surveillance Program (BSP) in Hospitalized Patients
    Gordon Dow, MD; Tim MacLaggan, BScPharm, ACPR; Jacques Allard, PhD
    Posters
  • Slide1.jpg (137.3 kB)
  • Impact of Education on Fluoroquinolone Use in Uncomplicated Cystitis
    Ryan Ferren, PharmD; Helen Lee, PharmD, BCPS; Steven Park, MD, PhD; Lauri Thrupp, MD, FIDSA, FSHEA; Lanny Hsieh, MD
    Effect of a Multifaceted Stewardship Intervention on Antibiotic Prescribing and Outcomes for Acute Bacterial Skin and Skin Structure Infections
    Danya Roshdy, PharmD; Rupal Jaffa, PharmD; Kelly E. Pillinger, PharmD; Josh Guffey, PharmD; Nigel Rozario, MS; Lisa Davidson, MD; Lewis Mccurdy, MD
    Posters
  • ABSSSI IDWeek poster 9-2017.pdf (841.5 kB)
  • Cost-Savings Associated With Delayed Switch To Outpatient Antibiotic Regimen For Patients Requiring Daptomycin Therapy
    Wenjing Wei, PharmD; Jessica Ortwine, PharmD; Norman Mang, PharmD; Kavita Bhavan, MD, MHS; Bonnie Prokesch, MD
    Posters
  • Dapto ID Week Poster final.pdf (214.5 kB)
  • Antimicrobial Stewardship Challenges: Could Generic Antibiotic Use Policies Improve Economic Outcomes in Acute Care Hospitals?
    Cristhian Hernández-Gómez, MSc; Max Feinstein, BA; Karen Ordóñez, MD; Sergio Reyes, MD; Christian Pallares, MD, MSc; Sergio Gutiérrez, Bac; Lorena Diaz, PhD; Obed Suárez, Pharm; Maria Virginia Villegas, MD, MSc, FIDSA
    Economic Outcomes of Isavuconazole to Prevent Invasive Fungal Infection in Immunocompromised Adults: Initial Experience at an Academic Medical Center
    Christina A. Kowalewska, PharmD; Gregory B. Tallman, PharmD; Aaron N. Pham, PharmD; James Lewis, PharmD, FIDSA
    Impact of a Standardized Penicillin Allergy Assessment Program to Optimize Penicillin Allergy Documentation and Beta-lactam Antibiotic Use at an Academic Medical Center
    Sandra Hanna, PharmD; Deverick Anderson, MD, MPH, FSHEA, FIDSA; Patricia Lugar, MD; Renee Kleris, MD; Rebekah W. Moehring, MD, MPH; Rebekah Wrenn, PharmD; Christina Sarubbi, PharmD
    Posters
  • PCN ID Week Poster 2017.pdf (349.8 kB)
  • Use of Penicillin Skin Testing as an Antimicrobial Stewardship Initiative: Clinical and Economic Evaluation at a Community Health System
    Bruce Jones, PharmD, BCPS; Joseph Crosby, PhD, RPh; Christopher Bland, PharmD, BCPS, FIDSA
    Posters
  • PST ID Week Poster PDF.pdf (734.1 kB)
  • Elimination of Aerosol Ribavirin Use In Immunocompromised Patients With Metapneumovirus and Parainfluenza Virus Infections.
    Emily Mui, PharmD; Marisa Holubar, MD, MS; Lina Meng, PharmD; Brian Blackburn, MD; Janjri Desai, PharmD; Stan Deresinski, MD, FIDSA
    Posters
  • IDWeek 2017 - Mui.E.pdf (135.5 kB)
  • Antipseudomonal Drug Exposure Associated with MDR Organisms in the Liver and Lung Transplant Population
    Surafel G Mulugeta, PharmD, MS; Michael P Veve, PharmD; Arin S Jantz, PharmD; Odaliz Abreu Lanfranco, MD; Susan L Davis, PharmD
    Posters
  • MulugetaS_IDWeek2017.pdf (250.1 kB)
  • Enhancing Antibiotic Stewardship Team (AST) Efforts in Decreasing Inappropriate Vancomycin Usage in Neutropenic Fever (NF) Patients through Unit Based Pharmacist Intervention
    Sarah Perreault, PharmD; Kejal Amin, PharmD MBA; Stephen Daleo, PharmD; Michelle Nadeau Nguyen, PharmD; Dayna McManus, PharmD, BCPS AQ-ID; Jeffrey Topal, MD; Maricar Malinis, MD, FACP, FIDSA
    Unintended Consequences of Pre-transplant VRE Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients
    Erica Stohs, MD, MPH; Trenton MacAllister, MS; Steven Pergam, MD, MPH, FIDSA; Rupali Jain, Pharm.D., FIDSA; Catherine Liu, MD, FIDSA
    Posters
  • VREABX_Poster_9.28.17 final.pdf (917.3 kB)
  • Evaluation of a Risk Stratification Guideline for the Treatment of Neutropenic Fever in Oncology Patients
    Amber Wollenziehn, PharmD; Sara Revolinski, PharmD, BCPS; Aaron Lorge, PharmD; J Njeri Wainaina, MD; Angela Huang, PharmD, BCPS-AQ ID
    Posters
  • NF IDweek poster_final.pdf (1.8 MB)
  • Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
    Nan Wang, PharmD; Elizabeth Neuner, PharmD, BCPS (AQ-ID); Jessica Bollinger, PharmD; Michael Spinner, PharmD; Kyle Brizendine, MD; Vasilios Athans, PharmD
    Impact of an Antimicrobial Stewardship Initiative Focused on Staphylococcus aureus Bacteremia
    Eric Gregory, PharmD; Katie Wallace, PharmD; Donna R. Burgess, RPh; Aric Schadler, MS; David S. Burgess, PharmD, FCCP, FIDP
    Posters
  • Gregory IDWeek SAB Poster.pdf (735.1 kB)
  • Impact of an Unsolicited, Simple Standardized Form Based Antimicrobial Stewardship Intervention to Improve Guideline Adherence in the Management of Staphylococcus aureus Bacteremia
    Shahileen Remtulla, B.Sc., B.Sc.(Pharm), PharmD; Karen Zurek, B.Sc.Pharm; Cristina Hernandez, MD; Carlos Cervera, MD; Holly Hoang, MD, FRCPC
    Posters
  • IDSA SAB poster Aug2017.pdf (1.0 MB)
  • Use of Diagnosis Related Group-Based Days of Therapy to Evaluate Fluoroquinolone Use Optimization Across a Large Healthcare System
    Jacinta Chin, PharmD, BCPS; David Priest, MD; Michael Gooch, MS, RPh; Sarah Green, PharmD, BCPS; Lacie McKamey, PharmD, BCPS; Lisa Blanchette, PharmD, BCPS-AQ ID
    Impact of an Emergency Medicine Pharmacist on Appropriate Empiric Antibiotic Prescribing for Community-Acquired Pneumonia and Intra-Abdominal Infections
    Benjamin Kulwicki, PharmD; Kasey Brandt, PharmD, BCPS; Heather Draper, PharmD, BCPS; Andrew Weise, MD; Lisa Dumkow, PharmD, BCPS
    De-escalation of Broad Spectrum Antibiotics Following Negative Cultures in Pneumonia: Rates and Outcomes
    Abhishek Deshpande, MD, PhD; Sandra S. Richter, MD; Sarah Haessler, MD; Kyle Brizendine, MD; Peter Lindenauer, MD, MSc; Pei-Chun Yu, MS; Marya D. Zilberberg, MD, MPH; Peter Imrey, PhD; Thomas Higgins, MD, MBA; Michael Rothberg, MD, MPH
    Evaluation of the Empiric use of Levofloxacin in Combination with Antipseudomonal Beta-Lactams for the Treatment of Pneumonia
    Jon Bachna, PharmD; Evan Abrass, PharmD; Craig Pleiman, PharmD; Steven Burdette, MD, FIDSA
    Posters
  • JBachna IDweek poster.pdf (596.7 kB)
  • Potential Impact of the DRIP Score on Antibiotic Use: a Retrospective Single-Center Study
    Danielle Babbel, MD; Jesse Sutton, PharmD; Richard Rose, MD; Peter Yarbrough, MD; Emily Spivak, MD, MHS
    Posters
  • DRIP score poster BABBEL 2 .pdf (536.0 kB)
  • Impact of Antimicrobial Stewardship Program Guidance on the Management of Community-Acquired Pneumonia in Hospitalized Adults
    Thomas Walsh, MD; Matthew Moffa, DO; Holly Bean, DO; Courtney Watson, MPH; Derek Bremmer, PharmD, BCPS
    Posters
  • ABSCAP (1).pdf (402.5 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.